ࡱ> 463 bjbjVV 4<<  //// ;/ >OOOOO***u w w w w w w #%Bw *****w OO *^OOu *u :q,O|m/ a  0 .%%%*******w w *** ****%********* : DRUG DEVELOPMENT WITH BIO-BUSINESS (MSc/PgDip/PgCert) 57B2DBB1/61B2DBVX/62B2DBVZ Qualifications for entry: A degree or equivalent qualification, at the prescribed standard in Medicine, Pharmacology, Pharmacy or a relevant Science subject (e.g. Biochemistry, Biomedical Sciences, Biology). Duration: 12 months full-time or 24 months part-time (MSc); 9 months full-time or 18 months part-time (PgDip). Aim: To equip students for careers in the development, use and knowledge of new and current drugs. To achieve this the programme will provide a multi-disciplinary approach to the study of drug discovery and development; mechanisms of drug action; preclinical and clinical trials; regulatory affairs and the Business of Science including entrepreneurship. Content: The programme of taught courses will comprise lectures, tutorials, practical classes and directed self-learning. The curriculum excludes biochemical and molecular aspects of drug action; drug transport, metabolism and excretion; toxicology; pharmacokinetics; statistics; computing studies; industrial aspects of drug development; therapeutics; therapeutic drug monitoring; the influence of disease on drug handling; drug-drug interactions; the design and conduct of volunteer and clinical trials; monitoring drug safety. There will be an introduction to the commercial, legal (intellectual property) and ethical aspects of todays bio-business world. Candidates shall be required to attend the following designated programme of courses: Stage 1 BT 5011 Introduction to Biobusiness and the Commercialisation of Bioscience Research (10 credit points) GS 50M1 Generic Skills (0 credit points) MT 5003 Drug Metabolism and Toxicology (15 credit points) MT 5004 Therapeutics (10 credit points) MT 5010 Basic Skills Induction (0 credit points) MT 5014 Molecular Pharmacology, Drug Discovery and Development (20 credit points) PU 5005 Applied Statistics (10 credit points) SK 5003 Information Skills (0 credit points) Elective MB 5015 Molecular Biology Basics & Cloning Lab (15 credit points) Stage 2 BT 5901 Laboratory Techniques Core Practical Skills (10 credit points) additional for students taking lab based research projects BT 5506 Business of Science (5 credit points) BT 5508 Advanced Bio-Business and the Commercialisation of Bioscience Research (15 credit points) MT 5501 Pharmacovigilance (5 credit points) MT 5502 Drug Development to Evidence Based Medicine (20 credit points) MT 5503 Pharmacokinetics (10 credit points) MT 5506 Omics and research (5 credit points) Diploma candidates may be allowed to transfer to the MSc if they complete the above programme at an appropriate standard. No candidate will be allowed to progress to Stage 3 as an MSc candidate if they fail to achieve an appropriate standard in the above programme. MSc candidates with a registered medical qualification may be able to carry out a clinical research project in the final stage under supervision of one of the medical staff. Stage 3 MSc only MT 5810 Research Project (65 credit points) PgDip only MT 5809 Dissertation (20 credit points) Assessment: By practical work, by written essays and by oral presentations, or by a combination of these, as prescribed for each course. The thesis/dissertation will be assessed and there may be an oral examination on completion of the programme. Candidates must pass all courses at an appropriate standard for the award of the MSc degree. QRk$ -  [,7͸ h-hCJh>*OJQJ^J)hh56>*CJOJQJ^JaJhhOJQJ^JaJh6OJQJ]^Jh5OJQJ\^JhOJQJ^JQR# $ [k |^`|gdgdgd  06$gd  0D%gd1]+,gd-gd |^`|gd gd21h:p[=. A!"#$% j 666666666vvvvvvvvv66666>66666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH nH sH tH N`N  Normal$a$ CJOJPJQJ_HmH sH tH `@` + Heading 2$<@&$56CJOJPJQJ\]^JaJ>@>   Heading 3$d8@&5XX = Heading 6 <@&5CJOJPJQJ\^JaJRR "2^ Heading 7 <@&CJOJPJQJ^JaJXX N$ Heading 8 <@&6CJOJPJQJ]^JaJDA D Default Paragraph FontRiR 0 Table Normal4 l4a (k ( 0No List PP  Heading 3 Char5CJOJPJQJ^JaJ\\ +Heading 2 Char(56CJOJPJQJ\]^JaJtH 44 +Header  9r B!B + Header CharCJOJPJQJtH V1V =Heading 6 Char"5CJOJPJQJ\^JaJtH PAP "2^Heading 7 CharCJOJPJQJ^JaJtH JZRJ w0 Plain Text$a$CJOJQJ^JtH FaF w0Plain Text CharOJPJQJ^JVQrV ft Body Text 3$ 0d6a$ 5OJQJPP ftBody Text 3 Char5CJOJPJQJtH VV N$Heading 8 Char"6CJOJPJQJ]^JaJtH 6U6 mO Hyperlink >*B*phPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK]   8@0(  B S  ?(-.4 9 J   3  zp>}z<<^<`o(.^`o(()zLz^z`L.J J ^J `.  ^ `.L^`L.^`.^`.ZLZ^Z`L. ^`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo(}zzp         ]Z BkwgH J&d =gu(,v[!)"Z%l.3g8x;[=Q@B|BsICJqKLyLw}MmOgNPk,QEuW^]"2^H_a;aMVataEcFe%'gQ=gy&jDzj\Al9o(tftvYxH y%z7g|4&}?7}sl a=w ~(u.t9aj +M7R.~N$h-mO|5$mg;Sdz9B}%R9g @ h@Unknown G*Ax Times New Roman5Symbol3. *Cx Arial7.{ @CalibriY CG TimesTimes New Roman7K@Cambria?= *Cx Courier New;WingdingsA BCambria Math"qh=f=f  !20~ ~ 3HP $P 2!xxRobertRobert  Oh+'0 px  RobertNormalRobert2Microsoft Office Word@F#@ :m@ :m ՜.+,0 hp|  ~   Title  !"$%&'()*,-./0125Root Entry FUm71Table&WordDocument4SummaryInformation(#DocumentSummaryInformation8+CompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q